Rocket Pharmaceuticals Ltd.
GRAND CAYMAN, E9 · Founded 2015 · CIK 0001663128 · Biotech · Public
Gene therapy treatments for rare genetic diseases
rocketpharma.com →- Grants
- —
- No SBIR or STTR on record
- Sector median: 1
- Raised
- $28M
- 2 Form D · Mar 2017
- 115 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 9
- 1 granted · 8 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201520162017
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $16,425,000 | |
| Private capital raised | Form D · SEC | $12,024,787 |
Form D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2467 | Vaxart, Inc. | — | $23M |
| 2468 | PULMOTECT, INC | — | $22M |
| 2469 | New Echota Biotechnology | — | — |
| 2470 | Rocket Pharmaceuticals Ltd. | — | $28M |
| 2471 | BIOSTRATEGIES LC | — | — |
| 2472 | Fulgent Pharma LLC | — | $5.4M |
| 2473 | Kestrel Therapeutics Inc. | — | $21M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Gaurav ShahExecutive Officer
- Roderick WongDirector
- Naveen YalamanchiDirector
Patents
- Gene Therapy Vectors For Treatment Of Danon Diseasegranted
- Gene Therapy Vectors For Treatment Of Danon Diseaseapplication
- Gene Therapy Vectors For Treatment Of Danon Diseaseapplication
- Gene Therapy Vectors For Infantile Malignant Osteopetrosisapplication
- Gene Therapy For Cns Degenerationapplication
- Gene Therapy Vectors For Treatment Of Danon Diseaseapplication
- Production methods for viral vectorsapplication
- Methods For Gene Modification Of Hematopoietic Cellsapplication
- Gene Therapy Vectors For Treatment Of Danon Diseaseapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.